These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19401628)

  • 1. Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.
    Iuliano AD; Feingold E; Wahed AS; Kleiner DE; Belle SH; Conjeevaram HS; Zmuda J; Liang TJ; Yee LJ;
    Intervirology; 2009; 52(1):49-56. PubMed ID: 19401628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race, insulin resistance and hepatic steatosis in chronic hepatitis C.
    Conjeevaram HS; Kleiner DE; Everhart JE; Hoofnagle JH; Zacks S; Afdhal NH; Wahed AS;
    Hepatology; 2007 Jan; 45(1):80-7. PubMed ID: 17187406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.
    Wójcik K; Jabłonowska E; Omulecka A; Piekarska A
    World J Gastroenterol; 2014 Aug; 20(30):10449-56. PubMed ID: 25132761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P
    J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
    Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.
    Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ
    J Viral Hepat; 2011 Apr; 18(4):e144-52. PubMed ID: 21070504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
    Cai T; Dufour JF; Muellhaupt B; Gerlach T; Heim M; Moradpour D; Cerny A; Malinverni R; Kaddai V; Bochud M; Negro F; Bochud PY
    J Hepatol; 2011 Sep; 55(3):529-535. PubMed ID: 21236304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.
    Aller R; De Luis DA; Izaola O; González Sagrado M; Conde R; Pacheco D; Velasco MC; Ovalle HF
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):335-41. PubMed ID: 22530350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.
    Khattab MA; Abdel-fattah ME; Eslam M; Abdelaleem A; Abdelaleem RA; Shatat M; Ali A; Hamdy L; Tawfek H
    J Clin Gastroenterol; 2010; 44(10):707-12. PubMed ID: 20195166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
    Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients.
    Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Micheloud D; Guzmán-Fulgencio M; Miralles P; Pineda-Tenor D; García-Álvarez M; López JC; Aldámiz-Echevarria T; Carrero A; Resino S
    J Viral Hepat; 2014 Mar; 21(3):189-97. PubMed ID: 24438680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.
    Pavlidis C; Panoutsopoulos GI; Tiniakos D; Koutsounas S; Vlachogiannakos J; Zouboulis-Vafiadis I
    World J Gastroenterol; 2011 Dec; 17(46):5097-104. PubMed ID: 22171144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Afsari A; Lee E; Shokrani B; Boortalary T; Sherif ZA; Nouraie M; Laiyemo AO; Alkhalloufi K; Brim H; Ashktorab H
    Dig Dis Sci; 2017 Aug; 62(8):2159-2165. PubMed ID: 28612194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.